pharmaceuticals-and-healthcare

Global Influenza Medication Market Insights, Forecast to 2025


Published On : Sep 2018

Category : Pharmaceutical

No. of Pages : 115 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Influenza Medication in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Influenza Medication in these regions.
This research report categorizes the global Influenza Medication market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
In 2017, the global Influenza Medication market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Influenza Medication market based on company, product type, application and key regions.

The various contributors involved in the value chain of Influenza Medication include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Influenza Medication include
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International GmbH (Novartis AG)
Sun Pharmaceutical Industries
Mylan

Market Size Split by Type
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other
Market Size Split by Application
Hospitals
Clinics
Pharmacies
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Influenza Medication market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Influenza Medication market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Influenza Medication manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Influenza Medication with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Influenza Medication submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Influenza Medication are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Influenza Medication market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global influenza medication market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global influenza medication market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global influenza medication market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global influenza medication market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global influenza medication market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global influenza medication market insights forecast to 2025, including the definition, classification, and industry chain structure of Global influenza medication market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global influenza medication market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global influenza medication market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global influenza medication market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global influenza medication market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global influenza medication market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global influenza medication market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Influenza Medication
Figure Global Influenza Medication Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Influenza Medication Production Market Share by Types (Product Category) in 2017
Figure Zanamivir Product Picture
Table Major Manufacturers of Zanamivir
Figure Oseltamivir Product Picture
Table Major Manufacturers of Oseltamivir
Figure Peramivir Product Picture
Table Major Manufacturers of Peramivir
Figure Amantadine Product Picture
Table Major Manufacturers of Amantadine
Figure Rimantadine Product Picture
Table Major Manufacturers of Rimantadine
Figure Inosine Product Picture
Table Major Manufacturers of Inosine
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Influenza Medication Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Pharmacies
Figure Others
Figure Influenza Medication Report Years Considered
Figure Global Influenza Medication Market Size 2016-2025 (Million US$)
Figure Global Influenza Medication Sales 2016-2025 (K Units)
Table Global Influenza Medication Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Influenza Medication Sales by Regions 2016-2025 (K Units)
Table Global Influenza Medication Sales Market Share by Regions 2016-2025
Figure Global Influenza Medication Sales Market Share by Regions 2016-2025
Figure 2017 Global Influenza Medication Sales Market Share by Regions
Table Global Influenza Medication Revenue by Regions 2016-2025 (Million US$)
Table Global Influenza Medication Revenue Market Share by Regions 2016-2025
Figure Global Influenza Medication Revenue Market Share by Regions 2016-2025
Figure 2017 Global Influenza Medication Revenue Market Share by Regions
Table Global Influenza Medication Sales by Manufacturers (2016-2018) (K Units)
Table Global Influenza Medication Sales Share by Manufacturers (2016-2018)
Figure Global Influenza Medication Sales Share by Manufacturers in 2017
Table Influenza Medication Revenue by Manufacturers (2016-2018) (Million US$)
Table Influenza Medication Revenue Share by Manufacturers (2016-2018)
Figure Influenza Medication Value Share by Manufacturers in 2017
Table Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Influenza Medication Price (2016-2018) (USD/Unit)
Table Influenza Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Influenza Medication Product Category
Table Date of International Manufacturers Enter into Influenza Medication Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Influenza Medication Sales by Type (2016-2025) (K Units)
Table Global Influenza Medication Sales Share by Type (2016-2025)
Figure Global Influenza Medication Sales Market Share by Type (2016-2025)
Figure Global Influenza Medication Sales Market Share by Type in 2017
Table Global Influenza Medication Revenue by Type (2016-2025) (Million US$)
Table Global Influenza Medication Revenue Share by Type (2016-2025)
Figure Global Influenza Medication Revenue Market Share by Type (2016-2025)
Figure Global Influenza Medication Revenue Market Share by Type in 2017
Table Influenza Medication Price by Type 2013-2018 (USD/Unit)
Table Global Influenza Medication Sales by Application (2016-2025) (K Units)
Table Global Influenza Medication Sales Share by Application (2016-2025)
Figure Global Sales Influenza Medication Market Share by Application (2016-2025)
Figure Global Sales Influenza Medication Market Share by Application (2016-2025)
Figure North America Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure North America Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table North America Influenza Medication Sales by Countries (2016-2025) (K Units)
Table North America Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 North America Influenza Medication Sales Market Share by Countries
Table North America Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table North America Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Influenza Medication Revenue Market Share by Countries
Figure United States Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure United States Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Canada Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table North America Influenza Medication Sales by Type (2016-2025) (K Units)
Table North America Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 North America Influenza Medication Market Share by Type
Table North America Influenza Medication Sales by Application (2016-2025) (K Units)
Table North America Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 North America Influenza Medication Market Share by Application
Table North America Influenza Medication Sales by Company (2016-2018) (K Units)
Table North America Influenza Medication Sales Market Share by Company (2016-2018)
Figure North America Influenza Medication Sales Market Share by Company in 2017
Figure Europe Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Europe Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Europe Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Influenza Medication Sales Market Share by Countries
Table Europe Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Europe Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Influenza Medication Revenue Market Share by Countries
Figure Germany Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Germany Influenza Medication Revenue Growth Rate (2016-2025) (K Units)
Figure France Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure France Influenza Medication Revenue Growth Rate (2016-2025) (K Units)
Figure UK Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure UK Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Italy Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Russia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Influenza Medication Sales by Type (2016-2025) (K Units)
Table Europe Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Europe Influenza Medication Market Share by Type
Table Europe Influenza Medication Sales by Application (2016-2025) (K Units)
Table Europe Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Europe Influenza Medication Market Share by Application
Table Europe Influenza Medication Sales by Company (2016-2018) (K Units)
Table Europe Influenza Medication Sales Market Share by Company (2016-2018)
Figure Europe Influenza Medication Sales Market Share by Company in 2017
Figure Asia Pacific Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Sales Market Share by Countries
Table Asia Pacific Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Revenue Market Share by Countries
Figure China Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure China Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Japan Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Korea Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure India Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure India Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Australia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Influenza Medication Sales by Type (2016-2025) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Market Share by Type
Table Asia Pacific Influenza Medication Sales by Application (2016-2025) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Influenza Medication Market Share by Application
Table Asia Pacific Influenza Medication Sales by Company (2016-2018) (K Units)
Table Asia Pacific Influenza Medication Sales Market Share by Company (2016-2018)
Figure Asia Pacific Influenza Medication Sales Market Share by Company in 2017
Figure Central & South America Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Influenza Medication Sales Market Share by Countries
Table Central & South America Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Influenza Medication Revenue Market Share by Countries
Figure Brazil Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Influenza Medication Sales by Type (2016-2025) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Influenza Medication Market Share by Type
Table Central & South America Influenza Medication Sales by Application (2016-2025) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Influenza Medication Market Share by Application
Table Central & South America Influenza Medication Sales by Company (2016-2018) (K Units)
Table Central & South America Influenza Medication Sales Market Share by Company (2016-2018)
Figure Central & South America Influenza Medication Sales Market Share by Company in 2017
Figure Middle East and Africa Influenza Medication Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Influenza Medication Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Influenza Medication Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Sales Market Share by Countries
Table Middle East and Africa Influenza Medication Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Influenza Medication Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Revenue Market Share by Countries
Figure GCC Countries Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Influenza Medication Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Influenza Medication Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Influenza Medication Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Market Share by Type
Table Middle East and Africa Influenza Medication Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Influenza Medication Market Share by Application
Table Middle East and Africa Influenza Medication Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Influenza Medication Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Influenza Medication Sales Market Share by Company in 2017
Table Daiichi Sankyo Company Company Details
Table Daiichi Sankyo Company Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Daiichi Sankyo Company Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Natco Pharma Company Details
Table Natco Pharma Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Natco Pharma Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Pharmaceutical Recent Development
Table Sandoz International GmbH (Novartis AG) Company Details
Table Sandoz International GmbH (Novartis AG) Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sandoz International GmbH (Novartis AG) Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sun Pharmaceutical Industries Recent Development
Table Mylan Company Details
Table Mylan Influenza Medication Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mylan Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Influenza Medication Value Chain
Table Typical Suppliers of Key Influenza Medication Raw Material
Table Influenza Medication Customers List
Table Influenza Medication Sales Channels
Table Influenza Medication Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top